Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 10 de 10
Filtrer
1.
JAAD Int ; 7: 78-85, 2022 Jun.
Article de Anglais | MEDLINE | ID: mdl-35373156

RÉSUMÉ

Background: Early detection of melanoma is critical for positive outcomes. However, access for the diagnosis of melanoma remains problematic for segments of the general population. Objective: To compare the rates of dermatology and family medicine practitioner acceptances for a public insurance (Medicaid) versus private insurance (Anthem Blue Cross) and clinic wait times for an appointment for a changing pigmented skin lesion concerning melanoma in rural and urban regions in California. Methods: Cross-sectional audit study between June 2017 and March 2019; scripted phone calls were made to dermatology and family medicine practices (FMPs). Results: Family medicine and dermatology practices in both regions had significantly decreased acceptance of Medicaid. Dermatology practices had 11.3% to 13.0% Medicaid acceptance rates that were less than FMP rates of 28% to 36%. In both regions, FMP wait times were 2.4- to 3.2-fold longer for public versus private insurance; there were little differences in wait times for the 2 insurance types in dermatology practices, in both regions. Limitations: Assessment of only 2 regions in the state of California. Conclusion: Delays at FMPs and insurance types limit access to melanoma screening in California for underserved segments of the general population, which has implications for melanoma outcomes and health policy.

2.
Rev Bras Cir Cardiovasc ; 29(3): 432-6, 2014.
Article de Anglais, Portugais | MEDLINE | ID: mdl-25372919

RÉSUMÉ

The entry of sodium and calcium play a key effect on myocyte subjected to cardiac arrest by hyperkalemia. They cause cell swelling, acidosis, consumption of adenosine triphosphate and trigger programmed cell death. Cardiac arrest caused by hypocalcemia maintains intracellular adenosine triphosphate levels, improves diastolic performance and reduces oxygen consumption, which can be translated into better protection to myocyte injury induced by cardiac arrest.


Sujet(s)
Solutions cardioplégiques , Arrêt cardiaque provoqué/méthodes , Hyperkaliémie , Hypocalcémie , Calcium/physiologie , Solutions cardioplégiques/pharmacologie , Humains , Illustration médicale , Potassium , Reproductibilité des résultats
3.
Rev. bras. cir. cardiovasc ; 29(3): 432-436, Jul-Sep/2014. tab, graf
Article de Portugais | LILACS | ID: lil-727151

RÉSUMÉ

A entrada de sódio e cálcio desempenham efeito chave no miócito submetido à parada cardíaca por hiperpotassemia. Eles provocam edema celular, acidose, consumo de trifosfato de adenosina e desencadeiam processo de morte celular programada. A parada cardíaca provocada por hipocalcemia mantém os níveis intracelulares de trifosfato de adenosina, melhora o rendimento diastólico e reduz o consumo de oxigênio, o que pode ser traduzido em melhor proteção do miócito às lesões provocadas pela parada cardíaca induzida.


The entry of sodium and calcium play a key effect on myocyte subjected to cardiac arrest by hyperkalemia. They cause cell swelling, acidosis, consumption of adenosine triphosphate and trigger programmed cell death. Cardiac arrest caused by hypocalcemia maintains intracellular adenosine triphosphate levels, improves diastolic performance and reduces oxygen consumption, which can be translated into better protection to myocyte injury induced by cardiac arrest.


Sujet(s)
Humains , Solutions cardioplégiques , Hyperkaliémie , Hypocalcémie , Arrêt cardiaque provoqué/méthodes , Calcium/physiologie , Solutions cardioplégiques/pharmacologie , Illustration médicale , Potassium , Reproductibilité des résultats
4.
Rev Bras Cir Cardiovasc ; 29(2): 156-62, 2014.
Article de Anglais, Portugais | MEDLINE | ID: mdl-25140464

RÉSUMÉ

INTRODUCTION: Solutions that cause elective cardiac arrest are constantly evolving, but the ideal compound has not yet been found. The authors compare a new cardioplegic solution with histidine-tryptophan-glutamate (Group 2) and other one with histidine-tryptophan-cetoglutarate (Group 1) in a model of isolated rat heart. OBJECTIVE: To quantify the fractal dimension and Shannon entropy in rat myocytes subjected to cardioplegia solution using histidine-tryptophan with glutamate in an experimental model, considering the caspase markers, IL-8 and KI-67. METHODS: Twenty male Wistar rats were anesthetized and heparinized. The chest was opened, the heart was withdrawn and 40 ml/kg of cardioplegia (with histidine-tryptophan-cetoglutarate or histidine-tryptophan-glutamate solution) was infused. The hearts were kept for 2 hours at 4ºC in the same solution, and thereafter placed in the Langendorff apparatus for 30 min with Ringer-Locke solution. Analyzes were performed for immunohistochemical caspase, IL-8 and KI-67. RESULTS: The fractal dimension and Shannon entropy were not different between groups histidine-tryptophan-glutamate and histidine-tryptophan-acetoglutarate. CONCLUSION: The amount of information measured by Shannon entropy and the distribution thereof (given by fractal dimension) of the slices treated with histidine-tryptophan-cetoglutarate and histidine-tryptophan-glutamate were not different, showing that the histidine-tryptophan-glutamate solution is as good as histidine-tryptophan-acetoglutarate to preserve myocytes in isolated rat heart.


Sujet(s)
Solutions cardioplégiques/pharmacologie , Acide glutamique/pharmacologie , Arrêt cardiaque provoqué/méthodes , Myocytes cardiaques/effets des médicaments et des substances chimiques , Animaux , Caspases/analyse , Modèles animaux de maladie humaine , Entropie , Fractales , Glucose/pharmacologie , Coeur/effets des médicaments et des substances chimiques , Immunohistochimie , Interleukine-8/analyse , Antigène KI-67/analyse , Mâle , Mannitol/pharmacologie , Chlorure de potassium/pharmacologie , Procaïne/pharmacologie , Rat Wistar , Reproductibilité des résultats , Facteurs temps
5.
Rev Bras Cir Cardiovasc ; 29(2): 249-54, 2014.
Article de Anglais, Portugais | MEDLINE | ID: mdl-25140476

RÉSUMÉ

The calcium paradox was first mentioned in 1966 by Zimmerman et al. Thereafter gained great interest from the scientific community due to the fact of the absence of calcium ions in heart muscle cells produce damage similar to ischemia-reperfusion. Although not all known mechanisms involved in cellular injury in the calcium paradox intercellular connection maintained only by nexus seems to have a key role in cellular fragmentation. The addition of small concentrations of calcium, calcium channel blockers, and hyponatraemia hypothermia are important to prevent any cellular damage during reperfusion solutions with physiological concentration of calcium.


Sujet(s)
Calcium/métabolisme , Lésions traumatiques du coeur/métabolisme , Myocytes cardiaques/métabolisme , Adénosine triphosphate/métabolisme , Animaux , Caféine/effets indésirables , Calcium/administration et posologie , Inhibiteurs des canaux calciques/pharmacologie , Perméabilité des membranes cellulaires , Dinitrophénols/métabolisme , Glycocalyx/métabolisme , Défaillance cardiaque/étiologie , Lésions traumatiques du coeur/étiologie , Lésions traumatiques du coeur/anatomopathologie , Humains , Lésion de reperfusion myocardique/métabolisme , Myocarde/métabolisme , Rats , Sodium/physiologie , Facteurs temps
6.
Rev. bras. cir. cardiovasc ; 29(2): 249-254, Apr-Jun/2014. tab, graf
Article de Portugais | LILACS | ID: lil-719408

RÉSUMÉ

O paradoxo do cálcio foi pela primeira vez citado em 1966 por Zimmerman et al. A partir daí, ganhou grande interesse por parte da comunidade científica internacional devido ao fato da ausência do íon cálcio produzir na célula muscular cardíaca dano semelhante à lesão de isquemia-reperfusão. Apesar de não serem conhecidos todos os mecanismos envolvidos no processo da lesão celular no paradoxo do cálcio, a conexão intercelular mantida somente pelo nexus parece ter papel chave na fragmentação celular. A adição de pequenas concentrações de cálcio, bloqueadores de canal de cálcio, hiponatremia ou hipotermia são importantes para evitar que haja lesão celular no momento da reperfusão com soluções com concentração fisiológica de cálcio.


The calcium paradox was first mentioned in 1966 by Zimmerman et al. Thereafter gained great interest from the scientific community due to the fact of the absence of calcium ions in heart muscle cells produce damage similar to ischemia-reperfusion. Although not all known mechanisms involved in cellular injury in the calcium paradox intercellular connection maintained only by nexus seems to have a key role in cellular fragmentation. The addition of small concentrations of calcium, calcium channel blockers, and hyponatraemia hypothermia are important to prevent any cellular damage during reperfusion solutions with physiological concentration of calcium.


Sujet(s)
Animaux , Humains , Rats , Calcium/métabolisme , Lésions traumatiques du coeur/métabolisme , Myocytes cardiaques/métabolisme , Adénosine triphosphate/métabolisme , Perméabilité des membranes cellulaires , Caféine/effets indésirables , Inhibiteurs des canaux calciques/pharmacologie , Calcium/administration et posologie , Dinitrophénols/métabolisme , Glycocalyx/métabolisme , Défaillance cardiaque/étiologie , Lésions traumatiques du coeur/étiologie , Lésions traumatiques du coeur/anatomopathologie , Lésion de reperfusion myocardique/métabolisme , Myocarde/métabolisme , Sodium/physiologie , Facteurs temps
7.
Rev. bras. cir. cardiovasc ; 29(2): 156-162, Apr-Jun/2014. tab, graf
Article de Portugais | LILACS | ID: lil-719409

RÉSUMÉ

Introdução: As soluções que provocam parada cardíaca eletiva estão em constante evolução, porém, o composto ideal ainda não foi encontrado. Os autores comparam uma nova solução cardioplégica com histidina-triptofano-glutamato (Grupo 2) com histidina-triptofano-cetoglutarato (Grupo 1) em modelo de coração isolado de rato. Objetivo: Quantificar a dimensão fractal e entropia de Shannon em miócitos de rato submetidos à cardioplegia utilizando solução histidina-triptofano com glutamato em modelo experimental, considerando-se os marcadores caspase, IL-8 e Ki-67. Métodos: Vinte ratos machos de raça Wistar foram anestesiados e heparinizados. O tórax foi aberto, realizado cardiectomia e infundido 40 ml/Kg de solução cardioplégica apropriada. Os corações foram mantidos por 2 horas na mesma solução a 4ºC e, após esse período, colocados em aparato de Langendorff por 30 minutos com solução de Ringer Locke. Foram feitas análises imunohistoquímicas para caspase, IL-8 e KI-67. Resultados: A dimensão fractal e a entropia de Shannon dos corações submetidos à parada cardíaca eletiva nos grupos 1 e 2 não foram diferentes. Conclusão: A quantidade de informações avaliada pela entropia de Shannon e a distribuição das mesmas (dada pela dimensão fractal) nas lâminas de coração de rato submetidas à cardioplegia com solução histidina-triptofano-acetoglutarato ou histidina-triptofano-glutamato não foram diferentes, o que mostra que a solução de histidina-triptofano-glutamato é tão boa quanto a histidina-triptofano-cetoglutarato na preservação dos miócitos em modelo de coração isolado de rato. .


Introduction: Solutions that cause elective cardiac arrest are constantly evolving, but the ideal compound has not yet been found. The authors compare a new cardioplegic solution with histidine-tryptophan-glutamate (Group 2) and other one with histidine-tryptophan-cetoglutarate (Group 1) in a model of isolated rat heart. Objective: To quantify the fractal dimension and Shannon entropy in rat myocytes subjected to cardioplegia solution using histidine-tryptophan with glutamate in an experimental model, considering the caspase markers, IL-8 and KI-67. Methods: Twenty male Wistar rats were anesthetized and heparinized. The chest was opened, the heart was withdrawn and 40 ml/kg of cardioplegia (with histidine-tryptophan-cetoglutarate or histidine-tryptophan-glutamate solution) was infused. The hearts were kept for 2 hours at 4ºC in the same solution, and thereafter placed in the Langendorff apparatus for 30 min with Ringer-Locke solution. Analyzes were performed for immunohistochemical caspase, IL-8 and KI-67. Results: The fractal dimension and Shannon entropy were not different between groups histidine-tryptophan-glutamate and histidine-tryptophan-acetoglutarate. Conclusion: The amount of information measured by Shannon entropy and the distribution thereof (given by fractal dimension) of the slices treated with histidine-tryptophan-cetoglutarate and histidine-tryptophan-glutamate were not different, showing that the histidine-tryptophan-glutamate solution is as good as histidine-tryptophan-acetoglutarate to preserve myocytes in isolated rat heart. .


Sujet(s)
Animaux , Mâle , Solutions cardioplégiques/pharmacologie , Acide glutamique/pharmacologie , Arrêt cardiaque provoqué/méthodes , Myocytes cardiaques/effets des médicaments et des substances chimiques , Caspases/analyse , Modèles animaux de maladie humaine , Entropie , Fractales , Glucose/pharmacologie , Coeur/effets des médicaments et des substances chimiques , Immunohistochimie , /analyse , /analyse , Mannitol/pharmacologie , Chlorure de potassium/pharmacologie , Procaïne/pharmacologie , Rat Wistar , Reproductibilité des résultats , Facteurs temps
8.
Rev. mex. ortop. traumatol ; 13(6): 579-82, nov.-dic. 1999. graf
Article de Espagnol | LILACS | ID: lil-276540

RÉSUMÉ

Se presenta una serie retrospectiva de 73 pacientes operados con 5 tipos de prótesis totales de la cadera. La indicación fue por osteoartritis en 73 por ciento de los casos, necrosis avascular en 11 por ciento y artritis reumatoide en el 10 por ciento. Las prótesis colocadas fueron: 15 Muller clásica, 11 Weller, 20 Muller autobloqueante, 12 Osteonics y 3 Response. Después de 5 años de evolución, se presentaron líneas de radiolucidez alrededor de la prótesis con mayor frecuencia en la de Muller clásica, con menor frecuencia en la Osteonics y ausente en el Response. La cirugía de revision fue más frecuente en la protesis de Muller clásica y menos frecuente en la Response, Muller autobloqueante y Osteonics


Sujet(s)
Humains , Mâle , Femelle , Adulte , Adulte d'âge moyen , Arthroplastie , Arthroplastie , Ciments osseux/usage thérapeutique , Prothèse de hanche , Orthopédie , Arthrite/chirurgie , Arthrite/thérapie , Coxarthrose/chirurgie , Coxarthrose/thérapie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...